Detalhe da pesquisa
1.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
Cell
; 173(6): 1439-1453.e19, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856956
2.
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Nature
; 558(7709): 307-312, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29849141
3.
Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
Clin Genet
; 103(1): 119-124, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089892
4.
Greater expectations: meeting clinical needs through broad and rapid genomic testing.
Clin Chem Lab Med
; 61(4): 654-661, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473133
5.
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice.
Mod Pathol
; 34(5): 904-921, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33311649
6.
Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.
Br J Cancer
; 120(1): 54-56, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478409
7.
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.
Blood
; 129(17): 2395-2407, 2017 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28246194
8.
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
J Neurooncol
; 145(2): 321-328, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31542863
9.
JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
Br J Haematol
; 182(1): 78-85, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767839
10.
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
Breast Cancer Res Treat
; 164(3): 627-638, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28500398
11.
Correction: Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice.
Mod Pathol
; 35(2): 288, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937903
12.
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(11): 1961-1967, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27478011
13.
Rapid fluorescence in situ hybridisation optimises induction therapy for acute myeloid leukaemia.
Br J Haematol
; 191(5): 935-938, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460058
14.
Longitudinal targeted next-generation sequencing in a patient with acute myeloid leukaemia.
Br J Haematol
; 186(6): 801, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206598
15.
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.
Br J Haematol
; 166(3): 369-74, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24761809
16.
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
Haematologica
; 99(5): 821-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24463215
17.
Cytogenetics and genomics of acute myeloid leukemia.
Best Pract Res Clin Haematol
; 37(1): 101533, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490763
18.
RAD21 mutations in acute myeloid leukemia.
Leuk Lymphoma
; : 1-7, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506144
19.
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach.
Sci Rep
; 14(1): 4922, 2024 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418494
20.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Nat Med
; 30(4): 984-989, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266761